Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

The prevalence of diabetes around the world has reached epidemic proportions and is projected to increase to 642 million people by 2040. Diabetes is already the leading cause of end-stage kidney disease (ESKD) in most developed countries, and the growth in the number of people with ESKD around the w...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kidney international 2016-12, Vol.90 (6), p.1175-1183
Hauptverfasser:	Perkovic, Vlado, Agarwal, Rajiv, Fioretto, Paola, Hemmelgarn, Brenda R., Levin, Adeera, Thomas, Merlin C., Wanner, Christoph, Kasiske, Bertram L., Wheeler, David C., Groop, Per-Henrik, Bakris, George L., Cooper, Mark E., Chae, Dong-Wan, Davidson, Michael H., de Boer, Ian H., de Zeeuw, Dick, Fornoni, Alessia, Gnudi, Luigi, Herzog, Charles A., Hung, Adriana M., Jafar, Tazeen Hasan, Jardine, Meg, Jha, Vivekanand, Ji, Linong, Kahn, Steven E., Langham, Robyn G., Lerma, Edgar V., Ma, Ronald C.W., Makino, Hirofumi, Marre, Michel, Mauer, Michael, Metsärinne, Kaj, Nelson, Robert G., Pecoits-Filho, Roberto, Pollock, Carol A., Rajapurkar, Mohan, Rossing, Peter, Rychlík, Ivan, Sharma, Kumar, Stanton, Robert C., Tesař, Vladimír, Tikkanen, Ilkka, Tomson, Charlie R.V., Toto, Robert D., Tsukamoto, Yusuke, Tuttle, Katherine R., Wada, Takashi, Williams, Winfred W., Zhang, Hong, Zoungas, Sophia
Format:	Artikel
Sprache:	eng
Schlagworte:	antidiabetic agents cardiovascular disease chronic kidney disease diabetes Diabetic Nephropathies - therapy glycemic control Humans Renal Insufficiency, Chronic - therapy renoprotection
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!